CONMED Corporation

CNMD Healthcare Medical Devices

CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

46.72 0.42 −0.89%
Market cap
$1.4B
P/E
25.3×
Fwd P/E
8.8×
Dividend yield
0.00%
F-score
5/9
Altman Z
1.86
Beneish M
−2.70
Dividend safety
63/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
17.69 19.98 26.89 22.83

+8 more quarters

P/S ratio
0.72 0.79 0.92 1.08
P/FCF ratio
7.32 8.74 8.35 9.77
P/Operating CF
26.53 80.28 27.19 27.12
P/B ratio
0.95 1.06 1.22 1.44
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.30 1.39 1.49 1.69
EV/EBITDA
9.33 9.91 11.25 11.50
EV/Operating CF
11.83 13.37 12.03 13.54
EV/FCF
13.25 15.42 13.61 15.24
Quick Ratio
0.61 0.90 0.92 0.84
Current Ratio
1.48 2.29 2.14 2.10
Net Debt/EBITDA
14.10 18.14 13.93 25.65
Debt/Assets
36.27% 37.19% 35.90% 36.76%
Debt/Equity
0.80 0.85 0.81 0.85
Asset Turnover
0.59 0.59 0.59 0.58
Operating CF/Net income
1.61 0.97 2.77 18.78
Capex/Depreciation
(0.15) (0.14) (0.25) (0.26)
Interest Coverage
4.62 3.60 4.97 1.56
Research and Development Expense of Revenue
4.51% 5.15% 3.99% 4.11%
Selling, General and Administrative Expense of Revenue
42.37% 44.69% 44.68% 41.53%
Intangible Assets out of Total Assets
0.59 0.60 0.60 0.60
Share Based Compensation of Revenue
1.52% 1.74% 1.33% 1.36%
Graham Net Nets
(0.59) (0.58) (0.49) (0.45)
Graham Number
37.97 36.40 33.63 38.86
Earnings Yield
5.65% 5.01% 3.72% 4.38%
Free Cash Flow Yield
13.66% 11.44% 11.97% 10.23%
Revenue per Share
11.42 10.37 12.02 10.92
Operating CF per Share
1.23 0.44 1.49 1.73
Capex per Share
(0.10) (0.09) (0.16) (0.17)
Free Cash Flow per Share
1.14 0.35 1.33 1.57
Cash per Share
1.24 1.15 1.32 1.26
Shareholders Equity per Share
34.63 33.27 33.29 32.57
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
34.63 33.27 33.29 32.57
Free Cash Flow
34.16 10.58 41.22 48.50
Working Capital
220.27 377.88 357.82 347.46
Capital Expenditures
(2.93) (2.89) (5.11) (5.19)
Net Current Asset Value
(583.25) (626.68) (619.79) (652.07)
EV/EBIT
16.14 17.02 20.02 19.16
Capex to Sales
0.01 0.01 0.01 0.02
Price to Operating Income
8.92 9.65 12.28 12.29
Other line items
Average Receivables
236.96 224.90 242.78 228.09
Average Payables
101.04 100.57 97.95 105.83
Average Inventory
361.22 360.39 351.13 353.45
Average Assets
2,314.38 2,306.31 2,316.00 2,319.12
Average Common Equity
1,022.13 997.65 997.89 970.58

Fold the line items

Columns are period end dates